Stockscreener 앱 받기
220.64
0.05%
0.13
Cidara Therapeutics Inc 주식(CDTX)의 최신 뉴스
How Cidara Therapeutics Inc. (20D0) stock behaves under inflation pressureMarket Trend Report & Growth-Oriented Investment Plans - Newser
Analysts Shift to Hold as Cidara’s (CDTX) Recent Acquisition Deal Caps Upside - MSN
Cidara Therapeutics (NASDAQ:CDTX) Sets New 1-Year HighStill a Buy? - MarketBeat
RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck - Ashland Times-Gazette
Cidara Therapeutics stock hits 52-week high at 220.49 USD By Investing.com - Investing.com South Africa
Cidara Therapeutics stock hits 52-week high at 220.49 USD - Investing.com
Quadrature Capital Ltd Takes Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat
How resilient is Cidara Therapeutics Inc. stock in market downturnsNew Guidance & High Accuracy Trade Signal Alerts - Newser
Merck Commits $9.2 Billion to Acquire Cidara Therapeutics - MSN
Gainers Report: How resilient is Cidara Therapeutics Inc stock in market downturns2025 Top Gainers & Expert-Curated Trade Recommendations - BỘ NỘI VỤ
The American biopharm company Merck plans to raise $8 billion through the sale of bonds - AKM.RU
Cidara Therapeutics (NASDAQ:CDTX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Ensign Peak Advisors Inc Takes $244,000 Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Will Cidara Therapeutics Inc. (20D0) stock hit Wall Street targetsEarnings Recap Report & AI Driven Stock Price Forecasts - Newser
Merck Kicks Off US Dollar Bond Sale to Help Fund Cidara Deal - Bloomberg.com
Merck seeks up to US$8 bil in US bond sale tied to Cidara deal — Bloomberg - The Edge Singapore
Geode Capital Management LLC Grows Stock Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Intech Investment Management LLC Acquires Shares of 9,002 Cidara Therapeutics, Inc. $CDTX - MarketBeat
Street Watch: Why Cidara Therapeutics Inc. stock attracts high net worth investors - BỘ NỘI VỤ
3,783 Shares in Cidara Therapeutics, Inc. $CDTX Bought by Police & Firemen s Retirement System of New Jersey - MarketBeat
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer - AOL.com
Biotech Stocks To ConsiderNovember 25th - MarketBeat
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the MergerEXAS, SEE, CDTX, and MRSN - The Malaysian Reserve
Halper Sadeh LLC Encourages AXTA, SEMR, CDTX Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
hVIVO gains validation from Cidara’s takeover; broker calls it a "glowing endorsement" - Proactive Investors
Why Cidara Therapeutics Inc. stock attracts high net worth investors2025 Biggest Moves & Entry Point Confirmation Signals - BỘ NỘI VỤ
hVIVO PLCMSD to acquire Cidara - Research Tree
hVIVO welcomes MSD’s move to acquire Cidara in $9.2 billion deal - Vox Markets
hVIVO hails $9.2 billion Cidara takeover after key trial wins - Proactive financial news
Cidara Therapeutics (CDTX): Assessing Valuation After a 137% One-Month Surge - Yahoo Finance
Top Biotech Stocks To ConsiderNovember 20th - MarketBeat
Cidara Therapeutics (CDTX) Completes Enrollment for Crucial Phas - GuruFocus
Cidara Therapeutics Meets Target Enrollment for Phase 3 Trial of Potential Flu Preventative - MarketScreener
Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations - The Manila Times
Cidara Therapeutics Reaches Target Enrollment of Phase 3 - GlobeNewswire
Is Cidara Therapeutics Inc a good long term investmentStock Price Divergence & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Analysts Shift to Hold as Cidara's (CDTX) Recent Acquisition Deal Caps Upside - Finviz
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Q2 2025 Earnings Call Transcript - MSN
Top Biotech Stocks To Watch TodayNovember 21st - MarketBeat
10 Hottest SMID-Cap Stocks So Far In 2025 - Insider Monkey
Halper Sadeh LLC Encourages THS, CDTX, SPNS Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Promising Biotech Stocks To ConsiderNovember 18th - MarketBeat
Promising Mid Cap Stocks To ConsiderNovember 17th - MarketBeat
(CDTX) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Jefferies 25: Merck’s Cidara Buyout Could Help Meet Needs Of Increasingly Vaccine-Hesitant US - Citeline News & Insights
Merck Invests $9.2B in Cidara to Boost Breakthrough Flu Drug - BUCKSCO.Today
0.84%
0.90%
자본화:
|
볼륨(24시간):